# A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis

> **NCT07245992** · PHASE1 · RECRUITING · sponsor: **Philogen S.p.A.** · enrollment: 42 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** F8IL10

## Key facts

- **NCT ID:** NCT07245992
- **Lead sponsor:** Philogen S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2028-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07245992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07245992, "A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07245992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*